MaysonL, I believe the US position is to prevent patent violation in underdeveloped economies regardless of where the research was done or who owns the patent - this makes sense from an economic perspective given that the same could happen to a patent owned by an American firm.
However, I agree with you if you are suggesting that the US should not be strong-arming poorer countries into raising prices just to maintain the profits made by pharmaceutical companies.
